Soligenix is a late-stage biopharmaceutical company that develops and commercializes products that treat rare diseases. | NASDAQ: SNGX
www.soligenix.com
Location: United States, New Jersey, Princeton
Total raised: $4.82M
Investors 2
| Date | Name | Website |
| - | Medison Ve... | medisonven... |
| - | Pontifax V... | pontifax.c... |
Funding Rounds 5
| Date | Series | Amount | Investors |
| 19.04.2022 | - | $1.4M | - |
| 09.06.2021 | - | $865K | - |
| 09.03.2021 | - | $865K | - |
| 07.05.2020 | - | $840K | - |
| 18.12.2019 | - | $850K | - |
Mentions in press and media 11
| Date | Title | Description | Source |
| 10.11.2022 | An auction of 60 works from the late Microsoft co-founder Pa... | Georges Seurat's "Les Poseuses, Ensemble (Petite version)" fetched almost $150 million. Ch... | businessin... |
| 25.05.2022 | Soligenix, Inc. (NASDAQ: SNGX) Developing Treatments for Mul... | Soligenix NASDAQ SNGX SNGX Stock NASDAQ: SNGX Developing Treatments for Multiple Cancers; Vaccine... | einpresswi... |
| 16.08.2021 | Soligenix : Announces Recent Accomplishments And Second Quar... | PRINCETON, N.J. - Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmac... | marketscre... |
| 10.06.2021 | Soligenix Receives Pediatric Investigational Plan Waiver for... | PRINCETON, N.J., June 10, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Co... | prnewswire... |
| 20.05.2021 | Soligenix Receives Japanese Patent for Improved Production o... | PRINCETON, N.J., May 20, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Com... | prnewswire... |
| 19.01.2021 | Soligenix Announces Investor Webcast Event: U.S. Commerciali... | PRINCETON, N.J., Jan. 19, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Comp... | marketscre... |
| 11.12.2018 | Soligenix To Receive $611,000 in Non-Dilutive Funding | Soligenix, Inc. (Nasdaq: SNGX), a late-stage biopharmaceutical company focused on developing and com... | citybizlis... |
| 16.08.2017 | Feds offer up a new bonus plan for the R&D work they of... | As the nearly 1,000-page 21st Century Cures Act is implemented in phases, the full impact of... | endpts.com... |
| 14.08.2017 | Soligenix Receives $2.5M in Additional NIAID Funding | Soligenix, Inc. (Nasdaq: SNGX), a late-stage biopharmaceutical company focused on developing and com... | citybizlis... |
| 17.10.2016 | Soligenix To Receive $530,000 in Non-Dilutive Funding | Soligenix, Inc. (OTCQB: SNGXD) (Soligenix or the Company), a late-stage biopharmaceutical company fo... | citybizlis... |
Show more